Study: Immune regulation by IL-6 in Giant cell arteritis
Institution: Simon Fraser University, Burnaby, British Columbia Canada
Award: $50,000, one-year grant
Summary: Giant cell arteritis (GCA) is vascular disease that is characterized by thickening of the artery wall, resulting in a block in blood flow. It most often affects the temporal artery that provides blood to parts of the head is a challenging cause of blindness and stroke in the elderly. Targeting of arteries by cells of the immune system causes GCA. More specifically, T cells are specialized cells of the immune system that play a key role in the development of GCA.
The activation of T cell responses depends on the cytokine IL-6. IL-6 levels are increased in GCA and a clinical trial has recently begun to investigate the effect of blocking IL-6 activity on the development of GCA. However, the way in which IL-6 activates T cell responses in GCA is poorly understood.
We will study the potential mechanisms by which IL-6 affects immune responses in GCA by examining the relationship between IL-6 expression levels and features of T cell responses that are improperly controlled during the development of immune-mediated diseases.
The potential identification of correlations between IL-6 levels and altered properties of T cells will provide insight into how IL-6 alters immune function in GCA and will form the basis for future studies that specifically inhibit the activity of IL-6 in patients. Our studies will have implications for the management of GCA.
Watch an interview with Dr. Choy and Ben Wilson.